Literature DB >> 33920256

Recent Progress in Discovering the Role of Carotenoids and Their Metabolites in Prostatic Physiology and Pathology with a Focus on Prostate Cancer-A Review-Part I: Molecular Mechanisms of Carotenoid Action.

Joanna Dulińska-Litewka1, Yoav Sharoni2, Przemysław Hałubiec1, Agnieszka Łazarczyk1, Oskar Szafrański1, James A McCubrey3, Bartosz Gąsiorkiewicz1, Piotr Laidler1, Torsten Bohn4.   

Abstract

Among the vast variety of plant-derived phytochemicals, the group of carotenoids has continuously been investigated in order to optimize their potential application in the area of dietary intervention and medicine. One organ which has been especially targeted in many of these studies and clinical trials is the human prostate. Without doubt, carotenoids (and their endogenous derivatives-retinoids and other apo-carotenoids) are involved in intra- and intercellular signaling, cell growth and differentiation of prostate tissue. Due to the accumulation of new data on the role of different carotenoids such as lycopene (LC) and β-carotene (BC) in prostatic physiology and pathology, the present review aims to cover the past ten years of research in this area. Data from experimental studies are presented in the first part of the review, while epidemiological studies are disclosed and discussed in the second part. The objective of this compilation is to emphasize the present state of knowledge regarding the most potent molecular targets of carotenoids and their main metabolites, as well as to propose promising carotenoid agents for the prevention and treatment of prostatic diseases.

Entities:  

Keywords:  carotenoids; metabolism; nuclear receptors; prostate cancer; retinoids; transcription factors; xanthophylls

Year:  2021        PMID: 33920256      PMCID: PMC8069951          DOI: 10.3390/antiox10040585

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  107 in total

Review 1.  The nuclear receptor superfamily.

Authors:  Marc Robinson-Rechavi; Hector Escriva Garcia; Vincent Laudet
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

2.  A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Authors:  Paolo Gontero; Giancarlo Marra; Francesco Soria; Marco Oderda; Andrea Zitella; Francesca Baratta; Giovanna Chiorino; Ilaria Gregnanin; Lorenzo Daniele; Luigi Cattel; Bruno Frea; Paola Brusa
Journal:  Prostate       Date:  2015-04-20       Impact factor: 4.104

3.  Serum testosterone is reduced following short-term phytofluene, lycopene, or tomato powder consumption in F344 rats.

Authors:  Jessica K Campbell; Chad K Stroud; Manabu T Nakamura; Mary Ann Lila; John W Erdman
Journal:  J Nutr       Date:  2006-11       Impact factor: 4.798

4.  Lycopene modulates growth and survival associated genes in prostate cancer.

Authors:  Mohamed M Rafi; Saravanan Kanakasabai; Marynell D Reyes; John J Bright
Journal:  J Nutr Biochem       Date:  2013-06-05       Impact factor: 6.048

5.  Testosterone and food restriction modulate hepatic lycopene isomer concentrations in male F344 rats.

Authors:  T W Boileau; S K Clinton; S Zaripheh; M H Monaco; S M Donovan; J W Erdman
Journal:  J Nutr       Date:  2001-06       Impact factor: 4.798

6.  Molecular characterization of human prostate carcinoma cell lines.

Authors:  Adrie van Bokhoven; Marileila Varella-Garcia; Christopher Korch; Widya U Johannes; E Erin Smith; Heidi L Miller; Steven K Nordeen; Gary J Miller; M Scott Lucia
Journal:  Prostate       Date:  2003-11-01       Impact factor: 4.104

Review 7.  Carotenoids 2: Genetics and molecular biology of carotenoid pigment biosynthesis.

Authors:  G A Armstrong; J E Hearst
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

8.  Effect of conjugates of all-trans-retinoic acid and shorter polyene chain analogues with amino acids on prostate cancer cell growth.

Authors:  Eldem Sadikoglou; George Magoulas; Christina Theodoropoulou; Constantinos M Athanassopoulos; Efstathia Giannopoulou; Olga Theodorakopoulou; Denis Drainas; Dionysios Papaioannou; Evangelia Papadimitriou
Journal:  Eur J Med Chem       Date:  2009-03-28       Impact factor: 6.514

9.  Inhibitory Effects of Retinol Are Greater than Retinoic Acid on the Growth and Adhesion of Human Refractory Cancer Cells.

Authors:  Chuan Li; Masahiko Imai; Tomokazu Matsuura; Shinya Hasegawa; Masahiro Yamasaki; Noriko Takahashi
Journal:  Biol Pharm Bull       Date:  2016-01-26       Impact factor: 2.233

10.  Sex specific retinoic acid signaling is required for the initiation of urogenital sinus bud development.

Authors:  Sarah L Bryant; Jeffrey C Francis; Isabel B Lokody; Hong Wang; Gail P Risbridger; Kate L Loveland; Amanda Swain
Journal:  Dev Biol       Date:  2014-09-27       Impact factor: 3.582

View more
  3 in total

1.  Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance.

Authors:  Alexander L Semenov; Ekaterina A Gubareva; Elena D Ermakova; Anastasia A Dorofeeva; Irina A Tumanyan; Ekaterina A Radetskaya; Maria N Yurova; Saied A Aboushanab; Osman N Kanwugu; Elena I Fedoros; Andrey V Panchenko
Journal:  Plants (Basel)       Date:  2021-12-12

Review 2.  Are We Sentenced to Pharmacotherapy? Promising Role of Lycopene and Vitamin A in Benign Urologic Conditions.

Authors:  Piotr Kutwin; Piotr Falkowski; Roman Łowicki; Magdalena Borowiecka-Kutwin; Tomasz Konecki
Journal:  Nutrients       Date:  2022-02-18       Impact factor: 5.717

Review 3.  What Is the Current Direction of the Research on Carotenoids and Human Health? An Overview of Registered Clinical Trials.

Authors:  Daniela Martini; Letizia Negrini; Mirko Marino; Patrizia Riso; Cristian Del Bo; Marisa Porrini
Journal:  Nutrients       Date:  2022-03-11       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.